18 / 35
Page 35
Notes:
allied
academies
Journal of Dermatology Research and Skin Care | Volume 2
May 14-15, 2018 | Montreal, Canada
Spring Dermatology &
Skin Care Expo Conference
A
cne is one of the most prevalent diseases, especially
those aged 12 to 24 years. Currently, there are several
guidelines in the world, and in most, the treatment is based
according classification of the disease as comedonal, moderate
and severe. Propionibacterium acnes (P acnes) is implicated
in the physiopathology of acne, a Gram-positive anaerobe
that is implicated in the inflammatory phase of acne. Topical
therapy (benzoyl peroxide, topical, retinoids, topical antibiotics,
salicylic acid and azelaic acid) is a standard of care in acne
treatment. Systemic antibiotics (tetracycline, erythromycin and
Trimethoprim-sulfamethoxazole) are a standard of care in the
management of moderate and severe acne and treatment-
resistant forms of inflammatory acne. Oral antiandrogens,
such as spironolactone and cyproterone acetate, can be useful
in the treatment of acne. Oral isotretinoin is approved for the
treatment of severe recalcitrant nodular acne. Associated
therapies are chemical peels, comedone removal and
intralesional steroids.
Speaker Biography
Rodrigo Amaral is a Brazilian Dermatologist and is expertise in Surgical and Cosmetic
Dermatology. He is pursuing his Master’s degree in Health Science. He is the Director
of Clínica Dermis, Rio de Janeiro/RJ, Brazil and a Trainer in fillers and toxin botulinum
procedures.
e:
drigoamaral@yahoo.com.brRodrigo Amaral
Welfare Institute, Brazil
Exploring the different guidelines for treating acne vulgaris